Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Elevated Lipoprotein(a)”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)UnknownNCT00633698
What this trial is testing

Evaluation of the Effect of NICOtinic Acid (Niacin) on Elevated Lipoprotein(a) Levels (NICOLa Study)

Who this might be right for
Elevated Lipoprotein(a) Levels
Charite University, Berlin, Germany 150
Testing effectiveness (Phase 2)Study completedNCT00768274
What this trial is testing

Safety, Pharmacokinetic Study of RVX000222 in Healthy Subjects and Subjects With Low HDL Cholesterol

Who this might be right for
DyslipidemiaAtherosclerosisAcute Coronary Syndrome+1 more
Resverlogix Corp 72
Not applicableNot Yet RecruitingNCT07206160
What this trial is testing

Effect of Dapagliflozin on Interleukin 10 in Sepsis

Who this might be right for
Sepsis
Minia University 64
Testing effectiveness (Phase 2)Study completedNCT00689442
What this trial is testing

Safety and Efficacy Study of JTT-705 in Combination With Atorvastatin 20 mg in Patients With Low High-Density Lipoprotein (HDL) Levels

Who this might be right for
Dyslipidemia
Akros Pharma Inc. 105
Not applicableStudy completedNCT07579325
What this trial is testing

Lipid Screening Study

Who this might be right for
Lipoprotein (a)
University of Central Florida 35
Large-scale testing (Phase 3)Active Not RecruitingNCT05581303
What this trial is testing

Olpasiran Trials of Cardiovascular Events and Lipoprotein(a) Reduction (OCEAN(a)) - Outcomes Trial

Who this might be right for
Atherosclerotic Cardiovascular Disease
Amgen 7,297
Early research (Phase 1)Study completedNCT05896969
What this trial is testing

Dose Escalation of SNK-396 in Participants With Elevated Low-Density Lipoprotein Cholesterol

Who this might be right for
Elevated Low-Density Lipoprotein Cholesterol
Syneos Health 41
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07640217
What this trial is testing

A Phase II Clinical Study of SYH2068 Injection in Adults With Elevated Lipoprotein(a)

Who this might be right for
Adult Participants With Elevated Lipoprotein(a)
CSPC Zhongnuo Pharmaceutical (Shijiazhuang) Co., Ltd. 120
Large-scale testing (Phase 3)Study completedNCT02476006
What this trial is testing

Safety, Tolerability, and Effect of Alirocumab in High Cardiovascular Risk Patients With Severe Hypercholesterolemia Not Adequately Controlled With Conventional Lipid-modifying Therapies (ODYSSEY APPRISE)

Who this might be right for
Hypercholesterolemia
Sanofi 998
Not applicableStudy completedNCT07390604
What this trial is testing

Case Series : Management of Elevated Lipoprotein(a) Using Double-Filtration Plasmapheresis (DFPP) in Hemodialysis Patients With Chronic Kidney Disease ; ( LiPo-A )

Who this might be right for
Lipoprotein(a)Lipoprotein-apheresisDouble-filtration Plasmapheresis+2 more
Centre Hospitalier Régional Metz-Thionville 5
Testing effectiveness (Phase 2)Study completedNCT01890967
What this trial is testing

LY3015014 in Participants With High Cholesterol

Who this might be right for
Hypercholesterolemia
Eli Lilly and Company 527
Very early researchStudy completedNCT05178550
What this trial is testing

A Study in Healthy Participants Investigating Biomarkers After Exposure to Heparin When Heparin is Administered in the Fasted State or After a High-fat Meal. Heparin, a Registered Drug, is an Anticoagulant (Blood Thinner) That Prevents the Formation of Blood Clots.

Who this might be right for
Healthy Volunteers
Novo Nordisk A/S 12
Large-scale testing (Phase 3)Study completedNCT01492361
What this trial is testing

AMR101 to Evaluate Its Ability to Reduce Cardiovascular Events in High-Risk Patients With Hypertriglyceridemia and on Statin

Who this might be right for
Cardiovascular Diseases
Amarin Pharma Inc. 8,179
Testing effectiveness (Phase 2)Study completedNCT00697203
What this trial is testing

Assess the Effect of RO4607381 in Patients With Relatively Low Levels of High Density Lipoprotein-Cholesterol (HDL-C)

Who this might be right for
Dyslipidemia
Hoffmann-La Roche 292
Early research (Phase 1)Looking for participantsNCT07626281
What this trial is testing

Assessment of Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of a New Formulation of Inclisiran Containing Polysorbate 80 Compared to the Currently Marketed Formulation

Who this might be right for
Inclisiran Formulation
Novartis Pharmaceuticals 120
Large-scale testing (Phase 3)Study completedNCT00092638
What this trial is testing

An Investigational Drug Study in Patients With Elevated Cholesterol and Coronary Heart Disease (0653-804)(COMPLETED)

Who this might be right for
HypercholesterolemiaCoronary Disease
Organon and Co 450
Early research (Phase 1)Not Yet RecruitingNCT07804160
What this trial is testing

A Single Ascending Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of SAL0195 Injection in Participants With or Without Elevated Lipoprotein(a)

Who this might be right for
Elevated Lipoprotein(a)
The Third Xiangya Hospital of Central South University 40
Not applicableUnknownNCT05323227
What this trial is testing

Lp(a) With CCTA Assessed Parameters and Clinical Outcomes

Who this might be right for
Coronary Artery Disease
Shanghai Zhongshan Hospital 378
Large-scale testing (Phase 3)Study completedNCT02729025
What this trial is testing

Effects of Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) Inhibition on Arterial Wall Inflammation in Patients With Elevated Lipoprotein(a) (Lp(a))

Who this might be right for
Subjects With Hyperlipidemia, Dyslipidemia
Amgen 129
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07729475
What this trial is testing

A Phase II, Randomized, Double-Blind, Placebo-Controlled Study of Oral SAL0137 in Adults With Elevated Lp(a) and Increased Risk of Cardiovascular Events

Who this might be right for
Elevated Lipoprotein(a)
Shenzhen Salubris Pharmaceuticals Co., Ltd. 120
Next Page